Cardioprotective effects of hydrogen sulfide and its potential therapeutic implications in the amelioration of Duchenne muscular dystrophy cardiomyopathy

2024
journal article
review article
2
dc.abstract.enHydrogen sulfide ($H_{2}S$) belongs to the family of gasotransmitters and can modulate a myriad of biological signaling pathways. Among others, its cardioprotective effects, through antioxidant, anti-inflammatory, anti-fibrotic, and proangiogenic activities, are well-documented in experimental studies. Cardiorespiratory failure, predominantly cardiomyopathy, is a life-threatening complication that is the number one cause of death in patients with Duchenne muscular dystrophy (DMD). Although recent data suggest the role of $H_{2}S$ in ameliorating muscle wasting in murine and Caenorhabditis elegans models of DMD, possible cardioprotective effects have not yet been addressed. In this review, we summarize the current understanding of the role of $H_{2}S$ in animal models of cardiac dysfunctions and cardiac cells. We highlight that DMD may be amenable to $H_{2}S$ supplementation, and we suggest $H_{2}S$ as a possible factor regulating DMD-associated cardiomyopathy.pl
dc.affiliationWydział Biochemii, Biofizyki i Biotechnologii : Zakład Biotechnologii Medycznejpl
dc.contributor.authorŁoboda, Agnieszka - 130081 pl
dc.contributor.authorDulak, Józef - 127818 pl
dc.date.accessioned2024-02-19T08:06:29Z
dc.date.available2024-02-19T08:06:29Z
dc.date.issued2024pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.additionalBibliogr.pl
dc.description.number2pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume13pl
dc.identifier.articleid158pl
dc.identifier.doi10.3390/cells13020158pl
dc.identifier.eissn2073-4409pl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/327260
dc.languageengpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa*
dc.rights.licenceCC-BY
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/legalcode.pl*
dc.share.typeotwarte czasopismo
dc.subject.enDuchenne muscular dystrophypl
dc.subject.enDMDpl
dc.subject.encardiomyopathypl
dc.subject.eniPSC-CMpl
dc.subject.eninduced pluripotent stem cell-derived cardiomyocytespl
dc.subject.enhydrogen sulfidepl
dc.subject.en$H_{2}S$pl
dc.subtypeReviewArticlepl
dc.titleCardioprotective effects of hydrogen sulfide and its potential therapeutic implications in the amelioration of Duchenne muscular dystrophy cardiomyopathypl
dc.title.journalCellspl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.abstract.enpl
Hydrogen sulfide ($H_{2}S$) belongs to the family of gasotransmitters and can modulate a myriad of biological signaling pathways. Among others, its cardioprotective effects, through antioxidant, anti-inflammatory, anti-fibrotic, and proangiogenic activities, are well-documented in experimental studies. Cardiorespiratory failure, predominantly cardiomyopathy, is a life-threatening complication that is the number one cause of death in patients with Duchenne muscular dystrophy (DMD). Although recent data suggest the role of $H_{2}S$ in ameliorating muscle wasting in murine and Caenorhabditis elegans models of DMD, possible cardioprotective effects have not yet been addressed. In this review, we summarize the current understanding of the role of $H_{2}S$ in animal models of cardiac dysfunctions and cardiac cells. We highlight that DMD may be amenable to $H_{2}S$ supplementation, and we suggest $H_{2}S$ as a possible factor regulating DMD-associated cardiomyopathy.
dc.affiliationpl
Wydział Biochemii, Biofizyki i Biotechnologii : Zakład Biotechnologii Medycznej
dc.contributor.authorpl
Łoboda, Agnieszka - 130081
dc.contributor.authorpl
Dulak, Józef - 127818
dc.date.accessioned
2024-02-19T08:06:29Z
dc.date.available
2024-02-19T08:06:29Z
dc.date.issuedpl
2024
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.additionalpl
Bibliogr.
dc.description.numberpl
2
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
13
dc.identifier.articleidpl
158
dc.identifier.doipl
10.3390/cells13020158
dc.identifier.eissnpl
2073-4409
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/327260
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa
dc.rights.licence
CC-BY
dc.rights.uri*
http://creativecommons.org/licenses/by/4.0/legalcode.pl
dc.share.type
otwarte czasopismo
dc.subject.enpl
Duchenne muscular dystrophy
dc.subject.enpl
DMD
dc.subject.enpl
cardiomyopathy
dc.subject.enpl
iPSC-CM
dc.subject.enpl
induced pluripotent stem cell-derived cardiomyocytes
dc.subject.enpl
hydrogen sulfide
dc.subject.enpl
$H_{2}S$
dc.subtypepl
ReviewArticle
dc.titlepl
Cardioprotective effects of hydrogen sulfide and its potential therapeutic implications in the amelioration of Duchenne muscular dystrophy cardiomyopathy
dc.title.journalpl
Cells
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
7
Views per month
Views per city
Ashburn
2
Krakow
2
Wroclaw
1
Downloads
loboda_dulak_cardioprotective_effects_of_hydrogen_2024.pdf
18